Andra AP fonden Sells 173,600 Shares of Ventas, Inc. $VTR

Andra AP fonden lowered its holdings in shares of Ventas, Inc. (NYSE:VTRFree Report) by 50.5% during the 3rd quarter, Holdings Channel.com reports. The firm owned 170,400 shares of the real estate investment trust’s stock after selling 173,600 shares during the quarter. Andra AP fonden’s holdings in Ventas were worth $11,926,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. NewEdge Advisors LLC grew its position in shares of Ventas by 856.1% in the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after buying an additional 7,097 shares during the last quarter. Empowered Funds LLC raised its stake in Ventas by 6.8% during the first quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after buying an additional 536 shares during the last quarter. Woodline Partners LP lifted its stake in shares of Ventas by 46.8% in the first quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock worth $2,532,000 after buying an additional 11,739 shares in the last quarter. Focus Partners Wealth lifted its holdings in shares of Ventas by 130.4% during the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after purchasing an additional 12,233 shares in the last quarter. Finally, Envestnet Asset Management Inc. boosted its holdings in Ventas by 19.0% in the second quarter. Envestnet Asset Management Inc. now owns 372,054 shares of the real estate investment trust’s stock worth $23,489,000 after purchasing an additional 59,522 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

Ventas Trading Down 0.1%

VTR stock opened at $86.38 on Friday. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.03. Ventas, Inc. has a 12-month low of $60.15 and a 12-month high of $87.87. The stock has a market cap of $41.03 billion, a price-to-earnings ratio of 159.96, a PEG ratio of 2.12 and a beta of 0.77. The business’s 50-day moving average is $80.00 and its 200 day moving average is $75.08.

Ventas (NYSE:VTRGet Free Report) last announced its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). The firm had revenue of ($1,229.71) million during the quarter, compared to analysts’ expectations of $1.53 billion. Ventas had a net margin of 4.31% and a return on equity of 2.09%. The company’s revenue for the quarter was up 21.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, sell-side analysts anticipate that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be given a dividend of $0.52 per share. The ex-dividend date is Tuesday, March 31st. This is a positive change from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. Ventas’s dividend payout ratio (DPR) is 355.56%.

Insider Transactions at Ventas

In other news, CFO Robert F. Probst sold 29,930 shares of the stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the completion of the transaction, the chief financial officer directly owned 138,434 shares in the company, valued at approximately $10,694,026.50. This represents a 17.78% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Carey S. Roberts sold 35,532 shares of Ventas stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the sale, the executive vice president owned 72,755 shares of the company’s stock, valued at approximately $6,184,175. This represents a 32.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 86,106 shares of company stock worth $6,931,397 in the last quarter. Company insiders own 0.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on VTR shares. Morgan Stanley set a $90.00 target price on Ventas in a report on Friday, February 13th. Royal Bank Of Canada increased their price target on Ventas from $83.00 to $91.00 and gave the company an “outperform” rating in a report on Tuesday, February 10th. Jefferies Financial Group restated a “buy” rating and issued a $93.00 price target on shares of Ventas in a report on Monday, December 15th. Argus set a $88.00 target price on Ventas in a report on Tuesday, February 10th. Finally, Scotiabank increased their price objective on Ventas from $74.00 to $80.00 and gave the company a “sector perform” rating in a report on Thursday, November 13th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Ventas has an average rating of “Moderate Buy” and a consensus price target of $86.87.

View Our Latest Stock Report on Ventas

Ventas Profile

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Further Reading

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTRFree Report).

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.